Molecule Structure

Scientific Name

Glipizide

Description of the Drug

Glipizide is a sulfonylurea medication used in Type 2 Diabetes to sensitize pancreatic beta cells and stimulate insulin release.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01067

Brand Name(s)

Glibenese, Glipizide, Glucotrol, Glucotrol xl, Minodiab 2.5, Minodiab 5

Company Owner(s)

Watson Laboratories Inc, Pfizer Inc, Apotex Inc, Oxford Pharmaceuticals Llc, Bristol Myers Squibb Co, Par Pharmaceutical Inc, Zydus Pharmaceuticals Usa Inc, Ani Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Sandoz Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Sulfonylurea receptor 1, Kir6.2 PROTEIN COMPLEX BLOCKER CHEMBL2096972

Unichem Links

Atlas glipizide
SureChEMBL SCHEMBL17094
PharmGKB PA449762
Human Metabolome Database HMDB0015200
WDI GLIPIZIDE
DrugBank DB01067
PubChem: Thomson Pharma 14906210
PubChem 3478
Mcule MCULE-5142805548
LINCS LSM-2251
Nikkaji J20.336J
BindingDB 50012956
EPA CompTox Dashboard DTXSID0040676
DrugCentral 1301
Brenda 88880
ChemicalBook CB9185001
Guide to Pharmacology 6821
GSRS 7f560c62-af87-436c-9cf9-044010781f8d
rxnorm GLIPIZIDE GLUCOTROL
ChEBI 5384
NIH Clinical Collection SAM002564210
ZINC ZINC000000537795